Level up your trading with our powerful tools and real-time insights all in one place.
The current 0HF9 market cap is 4.62B. The company's latest EPS is USD -0.5169 and P/E is -19.31.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 182.24M | 260.89M | 305.51M | 329.23M | 399.36M |
| Operating Income | -304.04M | -247M | -206.43M | -204.43M | -73.49M |
| Net Income | -356.39M | -276.85M | -250.46M | -236.57M | -151.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 850.21M | 886.52M | 905.14M | 724.17M | 777.88M |
| Total Liabilities | 373.78M | 600.14M | 597.77M | 601.12M | 617.71M |
| Total Equity | 476.43M | 286.38M | 307.37M | 123.05M | 160.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -250.42M | -233.29M | -202.49M | -166.58M | -69.09M |
| Investing | 95.15M | -13.58M | 78.76M | 92.32M | 98.06M |
| Financing | 217.5M | 262.86M | 212.07M | -7.46M | 61.68M |
| Market Cap | 4.62B |
| Price to Earnings Ratio | -19.31 |
| Price to Sales Ratio | 7.33 |
| Price to Cash Ratio | 11.85 |
| Price to Book Ratio | 18.27 |
| Dividend Yield | - |
| Shares Outstanding | 293.25M |
| Average Volume (1 week) | 1.7k |
| Average Volume (1 Month) | 3.74k |
| 52 Week Change | 0.00% |
| 52 Week High | 15.75 |
| 52 Week Low | 15.75 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Amicus Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.amicusrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
